<DOC>
	<DOCNO>NCT00462618</DOCNO>
	<brief_summary>The purpose pilot study assess feasibility patient accessibility order design adequately power study compare group cognitive behavioral therapy insomnia ( CBT-I ) quetiapine non-demented patient age 60 year old control bipolar disorder ( I II ) major depressive disorder suffer residual insomnia .</brief_summary>
	<brief_title>Group Cognitive Behavioral Therapy ( CBT I ) Vs. Quetiapine Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Age great equal 60 year . 2 . Patients history major affective disorder , include Bipolar disorder type I type II major depressive disorder , assess Structured Clinical Interview DSMIV ( SCID ) , currently remission . 3 . Difficulty start initiate sleep four times/week least 3 month history . 4 . Total Pittsburg Sleep Quality Index &gt; 5 . 1 . Patient acute mood episode assess SCID 2 . Patients sleep disruptive medical problem include : sleep apnea , restless leg syndrome , periodic limb movement , parasomnia , congestive heart failure , chronic pain chronic obstructive pulmonary disease assess medical history medical record review . 3 . Patients schizophrenia , primary anxiety disorder active substance abuse determine SCID . 4 . Patients history failure intolerance respond quetiapine . 5 . Patient positive Alcohol Use Disorders Identification Test ( AUDIT ) total score 8 . 6 . Patients dementia brain degenerative disease , cognitive disorder Mini Mental Status Examination ( MMSE ) score less equal 24 . 7 . Patients acute depressive , manic , hypomanic mixed state reflect SCID 8 . Patients concurrent sedating medication would confound interpretation result . This operationalized follow : Sedating medication must present stable dosage least 14 day prior enrollment study . If medication prescribe primary sleep aid , continue . Our rationale patient may need medication initial sedate effect plateaued 14 day . However , medication prescribe assist insomnia discontinue effective subject otherwise meet inclusion ad exclusion criterion current study . Medications taper clinically indicated patient sing informed consent prior baseline assessment .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Elderly</keyword>
	<keyword>Affective disorder</keyword>
</DOC>